市場調查報告書

酵素補充治療藥的全球市場:2019-2025年

Enzyme Replacement Therapy Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949653
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
酵素補充治療藥的全球市場:2019-2025年 Enzyme Replacement Therapy Market 2019-2025
出版日期: 2020年06月27日內容資訊: 英文
簡介

全球酵素補充治療藥的市場在預測期間內預計大幅度成長。高雪氏症的病例數的全球性增加等要素促進該市場的成長。各酵素類型中,預計α-半乳糖苷酶的部門保持主要的佔有率。各適應症中,預計高雪氏症的部門佔大幅佔有率。各地區中,預計北美地區顯示最大的佔有率,成長率中亞太地區表現高成長率。

本報告提供全球酵素補充治療藥的市場調查,市場定義和概要,市場成長的各種影響因素分析,相關法律,市場規模的變化、預測,酵素類型、適應症等各種區分的明細,競爭環境,各地區、主要國家的詳細分析,企業佔有率,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 市場概要、考察

  • 調查範圍
  • 分析師的見解、目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 主要策略分析
  • 主要企業分析

第4章 市場影響因素

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場分析、預測:各種區分

  • 酵素各類型
    • β-半乳糖苷酶
    • α-半乳糖苷酶
    • Gallsulfase
    • 其他
  • 各適應症
    • 法布瑞氏症
    • 高雪氏症
    • 龐貝氏症
    • 其他

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • AbbVie Inc.
  • Actelion Pharmaceuticals Ltd
  • Alexion Pharmaceuticals, Inc.
  • Amicus Therapeutics Inc.
  • Audentes Therapeutics Inc.
  • BioMarin Pharmaceutical Inc
  • Entrada Therapeutics, Inc.
  • Horizon Therapeutics plc
  • Leadiant Biosciences, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Pharming Group NV
  • Protalix BioTherapeutics Inc.
  • Recordati S.p.A.
  • Sanofi S.A.
  • Synspira Therapeutics Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • TEIJIN Ltd.
目錄
Product Code: OMR2021972

Global Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Enzyme Types (Agalsidase Beta, Agalsidase Alfa, Galsulfase, and Others), By Indication (Fabry Disease, Gaucher Disease, Pompe Disease, and Others), Forecast 2019-2025

The global enzyme replacement therapy market is anticipated to grow significantly during the forecast period. Enzyme replacement therapy involves the process of intravenous (IV) infusions to correct the enzyme deficiency in the patients. The major factor contributing to the growth of the market include the increasing cases of Gaucher disease across the globe. Enzyme replacement therapy doesn't cure the Gaucher disease, besides, it aids in controlling the symptoms of Gaucher disease.

The enzyme replacement therapy market is segmented on the basis of the enzyme types and indication. Based on the enzyme type, the market is sub-segmented into agalsidase beta, agalsidase alfa, gulsulfase, and others. Agalsidase alfa segment is expected to hold a major market share in the enzyme replacement therapy market. Based on the indication, the market is sub-segmented into Fabry disease, Gaucher disease, Pompeo disease, and others. Gaucher disease is expected to contribute a prominent share in the market.

Geographically, the study of the global enzyme replacement therapy market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global enzyme replacement therapy market during the forecast period. North America expected to hold a major share in the global enzyme replacement therapy market.

Some of the key players of the global enzyme replacement therapy market include Amicus Therapeutics Inc., Sanofi SA, BioMarin Pharmaceutical Inc., Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Protalix BioTherapeutics Inc. Teijin Ltd., and others. The market players are considerably contributing to the market growth by adopting various strategies to stay competitive in the market. For instance, in July 2019, Takeda Pharmaceutical Co. Ltd. announced the launch of the enzyme replacement therapy portfolio in India for the lysosomal storage disorders. The company's enzyme replacement therapy portfolio includes Idursulfase for hunter syndrome, Velaglucerase Alpha for Gaucher disease, and Agalsidase Alfa for Fabry disease.

Research Methodology

The market study of the global enzyme replacement therapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the government organizations, pharmaceutical industry, hospitals & clinics, government organizations, regulatory bodies, industry associates & experts, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Enzyme replacement therapy Market Research and Analysis by Enzyme Types

2. Global Enzyme replacement therapy Market Research and Analysis by Indication

The Report Covers:

  • Comprehensive research methodology of the global enzyme replacement therapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global enzyme replacement therapy market.
  • Insights about market determinants which are stimulating the global Enzyme replacement therapy market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Amicus Therapeutics Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. BioMarin Pharmaceuticals Inc.
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Sanofi SA
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Takeda Pharmaceutical Co. Ltd.
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments
    • 3.2.5. Horizon Therapeutics plc
      • 3.2.5.1. Overview
      • 3.2.5.2. Financial Analysis
      • 3.2.5.3. SWOT Analysis
      • 3.2.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints/Challenges
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Enzyme Replacement Therapy Market by Enzyme Types
    • 5.1.1. Agalsidase Beta
    • 5.1.2. Agalsidase Alfa
    • 5.1.3. Galsulfase
    • 5.1.4. Others
  • 5.2. Global Enzyme Replacement Therapy Market by Indication
    • 5.2.1. Fabry Disease
    • 5.2.2. Gaucher Disease
    • 5.2.3. Pompe Disease
    • 5.2.4. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AbbVie Inc.
  • 7.2. Actelion Pharmaceuticals Ltd
  • 7.3. Alexion Pharmaceuticals, Inc.
  • 7.4. Amicus Therapeutics Inc.
  • 7.5. Audentes Therapeutics Inc.
  • 7.6. BioMarin Pharmaceutical Inc
  • 7.7. Entrada Therapeutics, Inc.
  • 7.8. Horizon Therapeutics plc
  • 7.9. Leadiant Biosciences, Inc.
  • 7.10. Merck KGaA
  • 7.11. Pfizer Inc.
  • 7.12. Pharming Group NV
  • 7.13. Protalix BioTherapeutics Inc.
  • 7.14. Recordati S.p.A.
  • 7.15. Sanofi S.A.
  • 7.16. Synspira Therapeutics Inc.
  • 7.17. Takeda Pharmaceutical Co. Ltd.
  • 7.18. TEIJIN Ltd.

LIST OF TABLES

  • 1. GLOBAL ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ENZYME TYPES, 2018-2025 ($ MILLION)
  • 2. GLOBAL AGALSIDASE BETA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL AGALSIDASE ALFA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL GALSULFASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL OTHER ENZYMES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)
  • 7. GLOBAL ENZYME REPLACEMENT THERAPY FOR FABRY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL ENZYME REPLACEMENT THERAPY FOR GAUCHER DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL ENZYME REPLACEMENT THERAPY FOR POMPE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL ENZYME REPLACEMENT THERAPY FOR OTHER INDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ENZYME TYPES, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)
  • 15. EUROPEAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ENZYME TYPES, 2018-2025 ($ MILLION)
  • 17. EUROPEAN ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ENZYME TYPES, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ENZYME TYPES, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD ENZYME REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ENZYME REPLACEMENT THERAPY MARKET SHARE BY ENZYME TYPES, 2018 VS 2025 (%)
  • 2. GLOBAL ENZYME REPLACEMENT THERAPY MARKET SHARE BY INDICATION, 2018 VS 2025 (%)
  • 3. GLOBAL ENZYME REPLACEMENT THERAPY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD ENZYME REPLACEMENT THERAPY MARKET SIZE, 2018-2025 ($ MILLION)